Get short, timely messages from ScientiaAdvisors.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @ScientiaAdvisor.

Get updates via SMS by texting follow ScientiaAdvisor to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

ScientiaAdvisor

  1. @PatFTerry from @ScientiaAdvisor participating in Genome-wide Partnering & Dealmaking Conference in Boston this week bit.ly/JVartz
  2. @PatFTerry will deliver the keynote address on "The Road to Translation" at the Genomics Forum 2012 @ScientiaAdvisor bit.ly/JQkx2V
  3. I uploaded a @YouTube video youtu.be/f4N50Au-diA?a Anderson_Q&A_selection.m4v
  4. Dr. Anderson @ScientiaAdvisor. He talked about research done at the Wellman Center and what motivates their research bit.ly/M48O2w
  5. Read @ScientiaAdvisor blog: @pharmalot webcast recap on Biosimilars & FDA Guidelines: Opportunities & Implications bit.ly/JlQ8YF
  6. @ScientiaAdvisor Jonathan Pan comments on GSK's offer to acquire Human Genome Sciences @BioPharmInsight bit.ly/KIKlAk
  7. @PatFTerry comments on Possible Cut Backs of Medco's Personalized Medicine Programs bit.ly/Jf1jlBhttps://…
  8. Read the latest on our blog: @HGlorikian delivered keynote speech at the opening of Sony's Cambridge office bit.ly/KHQBCR
  9. @HGlorikian delivers keynote at Sony DADC’s Boston groundbreaking ceremony bit.ly/IE5SIC
  10. Jonathan Pan @ScientiaAdvisor presented @pharmalot webinar: Biosimilars & FDA Guidelines:Opportunities & Implications bit.ly/IQ6U1u
  11. Read @ScientiaAdvisor blog: Medical Devices Companies Targeting Non-Medical Applications: The Case of Neuromarketing bit.ly/HGaGhi
  12. Read @ScientiaAdvisor newest blog: Next Generation RegenerativeTherapies Leverage Biomaterial-Cell Combination bit.ly/HiFCCf
  13. Luminary Insights from Dr Patrice Milos, Boston Site Head - Pfizer’s Centers for Therapeutic Innovation. View video at bit.ly/HRyN88
  14. Stay tuned for video excerpts from Dr. Milos' visit on @ScientiaAdvisor bit.ly/ihzmuU
  15. Industry is trying to innovate new and effective ways of performing research to enable personalized medicine.
  16. We will eventually learn more about drug/physiological pathways, and this opportunity will become more available for translational research.
  17. No central nervous system biologics projects are being pursued by CTI due to the higher complication of these drug/physiological pathways.
  18. CTI has been around for a year and has already screened 300 proposals. This may be the beginning of a new business model of biologics R&D.